News from Pfizer
Stay current with all the latest and breaking news about Pfizer, compare headlines and perspectives between news sources on stories happening today. In total, 291 stories have been published about Pfizer which Ground News has aggregated in the past 3 months.
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Pfizer News
Latest News Stories
Pfizer · HungaryPfizer's first gene therapy treatment for B hemophilia has been approved in the United States. The drug could be introduced in this quarter, with its price of over $3.5 million making it one of the country's most expensive medications.See the Story
Pfizer can help serious patients: they received the approval to launch the groundbreaking drug onto the market.
Pfizer · HungaryThe Food and Drug Administration has approved Pfizer's drug called Beqvez, the first licensed gene therapy treatment for the company in the United States, designed specifically for adults with moderate to severe hemophilia B, CNBC reported.See the Story
Pfizer has made a huge announcement: they have received the license, they can also cure this serious disease - Pénzcentrum
PfizerThe agency tasked with drug regulation colluded with other regulators to develop cohesive messaging as independent investigations revealed Canadians were injected with materials not initially disclosed by the manufacturer.See the Story
Health Canada knew about contamination issues in Pfizer’s shots but rubber-stamped the booster doses anyway
100% Right coverage: 1 sources
Pfizer · United StatesPfizer’s profit plunged over 40 percent year over year in the first quarter, with the drugmaker blaming falling sales of its COVID-19 vaccine and antiviral treatment for the net income crunch.
In its first-quarter 2024 results, released on May 1, Pfizer reported total revenues of $14.9 billion, representing a revenue decline of 20 percent year over year from the $18.5 billion notched in the year-ago quarter.
Profit (net income) fell by a whoppin…See the Story
Pfizer Profit Crashes 44 Percent on Weak COVID-19 Vaccine Sales
100% Right coverage: 1 sources